[ad_1]
A brand new type of anticancer drug that acts as a "Trojan horse" to penetrate inside tumor cells has shown promise for patients with six different types of cancer.
In patients with advanced drug-resistant cancers, more than a quarter of cervical and bladder tumors and nearly 15% of ovarian and lung tumors responded to the new treatment.
The new innovative drug, called tisotumab vedotin (or television), releases a toxic substance that kills cancer cells from the inside. The results have been so positive that the drug is now switched to phase II cervical cancer trials and will be tested in a range of additional solid tumor cancers.
…
They observed responses in 27% of patients with bladder cancer, 26.5% of cervical cancer, 14% of ovarian cancer, 13% of an esophagus, 13% of a non-small cell lung and 7% of endometrial cancer (although not in men with prostate cancer) .
…
Television is currently being tested in other types of cancer, including cancers of the intestine, pancreas, squamous cell lung, as well as in the head and the eye. neck, as well as in a Phase II trial as a second-line treatment for cervical cancer.
Read the full original message: New anti-cancer drug "Trojan horse" looks promising in patients with various cancers
Source link
